— Know what they know.
Not Investment Advice

004310.KS KSC

Hyundai Pharmaceutical Co., Ltd.
1W: -5.9% 1M: +0.6% 3M: +48.9% YTD: -33.7% 1Y: +117.2% 3Y: +115.3% 5Y: +19.9%
₩8,340.00 ($6.20)
-140.00 (-1.65%)
 
Weekly Expected Move ±14.4%
₩5935 ₩7137 ₩8340 ₩9543 ₩10745
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 54 · ₩195.6B mcap · 22M float · 23.72% daily turnover
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩195.6B ($145.3M)
52W Range3500-15960
Volume522,815
Avg Volume5,161,994
Beta0.70
Dividend₩30.00
Analyst Ratings
No analyst coverage
Company Info
CEOSang-Jun Lee
Employees399
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2000-02-04
Hyundai Pharm Building
Seoul, SC 06121
KR
+82 2 2600 3800
About Hyundai Pharmaceutical Co., Ltd.

Headquartered in Seoul, South Korea, Hyundai Pharmaceutical Co., Ltd. is an international manufacturer and distributor of a diverse portfolio that includes pharmaceutical products, health food beverages, and medical equipment. The company's extensive offerings comprise both prescription (ETC) and over-the-counter (OTC) remedies, addressing a broad spectrum of therapeutic areas. These encompass conditions related to cardiovascular health, infectious diseases, the central nervous system, pain management, respiratory ailments, dermatological issues, digestive and endocrine system disorders, gynecological health, and ophthalmic care. Additionally, their range extends to nutritional supplements, diagnostic reagents, wound healing solutions, and treatments for allergies, arthritis, and anemia, among many others. The company was founded in 1965.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms